New Two-Drug attack on Tough-to-Treat colon cancer
NCT ID NCT07229872
Summary
This study is testing whether a new combination of two drugs can help control advanced colorectal cancer that has stopped responding to standard treatments. It will involve about 18 adults whose cancer has specific immune markers. Participants will receive an intravenous drug every three weeks and take a daily pill for two weeks of each cycle to see if this approach shrinks tumors and delays cancer growth.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.